Ppd Development, Lp
CAGE Code: 5HM64
NCAGE Code: 5HM64
Status: Discontinued
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 109359435
Summary
Ppd Development, Lp is a Discontinued Commercial Supplier with the Cage Code 5HM64 and is tracked by Dun & Bradstreet under DUNS Number 109359435..
Address
929 N Front St
Wilmington NC 28401-3331
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
Quintus Corp Hanby's, Inc. Gte Mobilnet Of The Southeast Inc Dupont Electronic Materials Inc Custom Computer Keene Corp Smithcraft Lighting Div Spm And L Corp Auto Compressor Co The Soundtronics, Inc. Carbone-Abrams Eva Garda Cl Atlantic, Inc Critical Cleaning Technology Refined Reports Inc American Medical Claims Processing Hammers & Wrenches Inc Network Connect, Inc Data Comm Warehouse Inc Sensable Technologies, Inc. Bloom Philanthropy Llc Walsh J D Computer Consulting
Frequently Asked Questions (FAQ) for CAGE 5HM64
- What is CAGE Code 5HM64?
- 5HM64 is the unique identifier used by NATO Organizations to reference the physical entity known as Ppd Development, Lp located at 929 N Front St, Wilmington NC 28401-3331, United States.
- Who is CAGE Code 5HM64?
- 5HM64 refers to Ppd Development, Lp located at 929 N Front St, Wilmington NC 28401-3331, United States.
- Where is CAGE Code 5HM64 Located?
- CAGE Code 5HM64 is located in Wilmington, NC, USA.
Contracting History for CAGE 5HM64 Most Recent 25 Records
- HHSO10033003T
- Igf::Ot::Igf Aspr-16-05933 -- Ppd (Rtor 005) - Clinical Services Described In Tasks 1 Through 15
- 5 Jul 2018
- Igf::Ot::Igf Aspr-16-05933 -- Ppd (Rtor 005) - Clinical Services Described In Tasks 1 Through 15
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $15,637,839.00
- Department Of Health And Human Services (Hhs)
- HHSO100201400003I
- Igf::Ot::Igf - Ppd - Csn Rfp
- 3 Feb 2019
- Igf::Ot::Igf - Ppd - Csn Rfp
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $1,000,000.00
- Department Of Health And Human Services (Hhs)
- HHSO10033003T
- Igf::Ot::Igf Aspr-16-05933 -- Ppd (Rtor 005) - Clinical Services Described In Tasks 1 Through 15
- 4 Feb 2019
- Igf::Ot::Igf Aspr-16-05933 -- Ppd (Rtor 005) - Clinical Services Described In Tasks 1 Through 15
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $15,637,839.00
- Department Of Health And Human Services (Hhs)
- HHSO10033002T
- Igf::Ot::Igf - Ppd Task Order From Rtor 0003 (H5n1 Clinical Study)
- 5 Jul 2018
- Igf::Ot::Igf - Ppd Task Order From Rtor 0003 (H5n1 Clinical Study)
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $6,070,672.00
- Department Of Health And Human Services (Hhs)
- 0026
- Labor - Option 4
- 4 Jun 2019
- Labor - Option 4
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $765,778.07
- Department Of Defense (Dod)
- HHSO100201400003I
- Igf::Ot::Igf - Ppd - Csn Rfp
- 4 Feb 2019
- Igf::Ot::Igf - Ppd - Csn Rfp
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $1,000,000.00
- Department Of Health And Human Services (Hhs)
- HHSN27100001
- Igf::Ot::Igf Phase I Clinical Trials For Development Of Neurotherapeutics Task Order #001 - Performance Area A - Administrative And Overall Clinical Operations Support
- 1 Jul 2016
- Igf::Ot::Igf Phase I Clinical Trials For Development Of Neurotherapeutics Task Order #001 - Performance Area A - Administrative And Overall Clinical Operations Support
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $325,443.00
- Department Of Health And Human Services (Hhs)
- HHSO10033002T
- Ppd Task Order From Rtor 0003 (H5n1 Clinical Study)
- 12 Aug 2019
- Ppd Task Order From Rtor 0003 (H5n1 Clinical Study)
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $6,181,634.00
- Department Of Health And Human Services (Hhs)
- 0037
- Contract Support- Labor
- 29 Nov 2018
- Contract Support- Labor
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $3,558,673.30
- Department Of Defense (Dod)
- 0049
- To Provide Psychiatric Technical Expertise In Support Of Preclinical And Clinical Trial Research On Pharmacotherapeutics, Including Fda-Regulated Trials.
- 18 Apr 2019
- To Provide Psychiatric Technical Expertise In Support Of Preclinical And Clinical Trial Research On Pharmacotherapeutics, Including Fda-Regulated Trials.
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $97,901.36
- Department Of Defense (Dod)
- HHSN271201500014A
- Collaborative Hubs Site Monitoring Support
- 28 Apr 2021
- Collaborative Hubs Site Monitoring Support
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $1,265,208.59
- Department Of Health And Human Services (Hhs)
- HHSO10033003T
- Igf::Ot::Igf Aspr-16-05933 -- Ppd (Rtor 005) - Clinical Services Described In Tasks 1 Through 15
- 6 Feb 2019
- Igf::Ot::Igf Aspr-16-05933 -- Ppd (Rtor 005) - Clinical Services Described In Tasks 1 Through 15
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $15,637,839.00
- Department Of Health And Human Services (Hhs)
- 0046
- Option Period Four - Labor
- 1 Apr 2019
- Option Period Four - Labor
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $89,366.18
- Department Of Defense (Dod)
- HHSN271201500014A
- Collaborative Hubs Site Monitoring Support
- 19 Jun 2020
- Collaborative Hubs Site Monitoring Support
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $1,457,794.81
- Department Of Health And Human Services (Hhs)
- 0028
- Labor,Document Scanning And Remediation
- 24 Oct 2018
- Labor,Document Scanning And Remediation
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $57,001.52
- Department Of Defense (Dod)
- 0039
- Labor
- 4 Dec 2018
- Labor
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $433,540.96
- Department Of Defense (Dod)
- 0039
- Labor
- 8 Feb 2019
- Labor
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $433,540.96
- Department Of Defense (Dod)
- HHSO100201400003I
- Ppd - Csn Rfp
- 27 Feb 2020
- Ppd - Csn Rfp
- Office Of Acq&Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $1,000,000.00
- Department Of Health And Human Services (Hhs)
- HHSO10033002T
- Igf::Ot::Igf - Ppd Task Order From Rtor 0003 (H5n1 Clinical Study)
- 4 Feb 2019
- Igf::Ot::Igf - Ppd Task Order From Rtor 0003 (H5n1 Clinical Study)
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $6,070,672.00
- Department Of Health And Human Services (Hhs)
- HHSO10033003T
- Ppd (Rtor 005) - Clinical Services Described In Tasks 1 Through 15
- 27 Sep 2016
- Ppd (Rtor 005) - Clinical Services Described In Tasks 1 Through 15
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $16,438,275.80
- Department Of Health And Human Services (Hhs)
- HHSO10033003T
- Ppd (Rtor 005) - Clinical Services Described In Tasks 1 Through 15
- 12 Aug 2019
- Ppd (Rtor 005) - Clinical Services Described In Tasks 1 Through 15
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $16,020,935.80
- Department Of Health And Human Services (Hhs)
- HHSN271201500014A
- Collaborative Hubs Site Monitoring Support
- 24 Jun 2020
- Collaborative Hubs Site Monitoring Support
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $1,404,552.97
- Department Of Health And Human Services (Hhs)
- W81XWH13P0269
- Exercise Optional Task. Testing Of 15% Paromomycin And 0.5% Gentamicin In A Hydrophilic Cream Base And Paromomycin Alone Cream (15% Paromomycin In The Same Hydrophilic Cream Base). The Base Requirement Is To Continue Stability Testing Of These Lots Plus Stability Testing Of One Newly Manufactured Lot Each. All Testing Must Be In Accordance The International Conference On Harmonisation Tripartite Guideline Q1a (R2) Stability Testing Of New Drug Substances And Products. Toxicity Testing Of Both Creams In A Rat Dermal Model Is Required In Accordance With Fda Communications. All Testing Must Be Conducted In Accordance With Good Laboratory Practices, 21Cfr Part 58. Test Data Will Be Used To Support The Safety Of Both Creams
- 7 Jun 2018
- Exercise Optional Task. Testing Of 15% Paromomycin And 0.5% Gentamicin In A Hydrophilic Cream Base And Paromomycin Alone Cream (15% Paromomycin In The Same Hydrophilic Cream Base). The Base Requirement Is To Continue Stability Testing Of These Lots Plus Stability Testing Of One Newly Manufactured Lot Each. All Testing Must Be In Accordance The International Conference On Harmonisation Tripartite Guideline Q1a (R2) Stability Testing Of New Drug Substances And Products. Toxicity Testing Of Both Creams In A Rat Dermal Model Is Required In Accordance With Fda Communications. All Testing Must Be Conducted In Accordance With Good Laboratory Practices, 21Cfr Part 58. Test Data Will Be Used To Support The Safety Of Both Creams
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $1,323,740.00
- Department Of Defense (Dod)
- HHSO100201400003I
- Ppd - Csn Rfp
- 11 Sep 2019
- Ppd - Csn Rfp
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $1,000,000.00
- Department Of Health And Human Services (Hhs)